UPS Healthcare, the pharma and life sciences division of UPS, has announced a series of facility expansions to its healthcare-dedicated warehouse and distribution network in key global markets.

This includes a new facility in Shanghai and up to 1.5m sq ft of good manufacturing practices (GMP) distribution space for coronavirus-related shipments.

UPS will also put up a new GDP-compliant space opening in Central and Eastern Europe and additional cold chain space coming online near its UPS Worldport® facility in Louisville, US.

UPS Healthcare noted that as part its ongoing pharma facility enhancements, it has committed to building additional cooler space (for storage at 2 to 8 degrees Celsius), and freezer space (for storage at -20 to -80 degrees Celsius) at the new cold chain warehouse in Louisville.

UPS Healthcare is also expanding its GDP facility space in Hungary, and GMP space in the United Kingdom through its Polar Speed subsidiary where it operates a dispensing pharmacy that serves more than 20,000 patients daily.

The new GMP warehouse and transportation hub will be located in the Midlands, UK, to further facilitate its clients’ growth needs.

“UPS Healthcare continues to build out a global distribution infrastructure that demonstrates our commitment to the healthcare industry," said Wes Wheeler, UPS Healthcare president.

“We will continue to innovate and expand our quality systems throughout our expanded network to further support more complex pharmaceutical and lab testing requirements.”